Despite a vast amount
of data generated by proteomic analysis on
cochlear fluid, novel clinically applicable biomarkers of inner ear
diseases have not been identified hitherto. The aim of the present
study was to analyze the proteome of human perilymph from cochlear
implant patients, thereby identifying putative changes of the composition
of the cochlear fluid perilymph due to specific diseases. Sampling
of human perilymph was performed during cochlear implantation from
patients with clinically or radiologically defined inner ear diseases
like enlarged vestibular aqueduct (EVA;
n
= 14),
otosclerosis (
n
= 10), and Ménière’s
disease (
n
= 12). Individual proteins were identified
by a shotgun proteomics approach and data-dependent acquisition, thereby
revealing 895 different proteins in all samples. Based on quantification
values, a disease-specific protein distribution in the perilymph was
demonstrated. The proteins short-chain dehydrogenase/reductase family
9C member 7 and esterase D were detected in nearly all samples of
Ménière’s disease patients, but not in samples
of patients suffering from EVA and otosclerosis. The presence of both
proteins in the inner ear tissue of adult mice and neonatal rats was
validated by immunohistochemistry. Whether these proteins have the
potential for a biomarker in the perilymph of Ménière’s
disease patients remains to be elucidated.